This two-year postdoctoral fellowship in Yuri Schwartz’s molecular epigenetics laboratory investigates MLL1-driven leukaemia. The project examines how MLL1 fusions affect epigenetic repression and alternative gene-expression programmes, and whether methyltransferase activity and particular substrates are essential to oncogenic transformation. The laboratory combines Drosophila and human-cell models with genetics, genomics and numerical simulation to study Polycomb and Trithorax regulation. The proposed start is 1 January 2027 or by agreement.
Closes